S&P 500   3,304.00 (+0.70%)
DOW   27,217.06 (+0.26%)
QQQ   271.42 (+1.46%)
AAPL   111.03 (+0.86%)
MSFT   206.40 (+1.91%)
FB   252.96 (+1.94%)
GOOGL   1,453.78 (+1.65%)
AMZN   3,106.19 (+4.92%)
NVDA   500.59 (-0.02%)
TSLA   430.67 (-4.17%)
BABA   273.91 (+0.03%)
CGC   16.03 (+1.84%)
GE   6.24 (-1.73%)
MU   49.54 (+0.79%)
AMD   77.10 (-1.08%)
T   28.59 (-0.14%)
F   6.83 (-0.58%)
ACB   7.34 (+16.14%)
GILD   63.40 (-1.26%)
NFLX   490.19 (+0.58%)
DIS   126.99 (+1.26%)
BAC   23.92 (-2.25%)
BA   156.07 (-0.18%)
S&P 500   3,304.00 (+0.70%)
DOW   27,217.06 (+0.26%)
QQQ   271.42 (+1.46%)
AAPL   111.03 (+0.86%)
MSFT   206.40 (+1.91%)
FB   252.96 (+1.94%)
GOOGL   1,453.78 (+1.65%)
AMZN   3,106.19 (+4.92%)
NVDA   500.59 (-0.02%)
TSLA   430.67 (-4.17%)
BABA   273.91 (+0.03%)
CGC   16.03 (+1.84%)
GE   6.24 (-1.73%)
MU   49.54 (+0.79%)
AMD   77.10 (-1.08%)
T   28.59 (-0.14%)
F   6.83 (-0.58%)
ACB   7.34 (+16.14%)
GILD   63.40 (-1.26%)
NFLX   490.19 (+0.58%)
DIS   126.99 (+1.26%)
BAC   23.92 (-2.25%)
BA   156.07 (-0.18%)
S&P 500   3,304.00 (+0.70%)
DOW   27,217.06 (+0.26%)
QQQ   271.42 (+1.46%)
AAPL   111.03 (+0.86%)
MSFT   206.40 (+1.91%)
FB   252.96 (+1.94%)
GOOGL   1,453.78 (+1.65%)
AMZN   3,106.19 (+4.92%)
NVDA   500.59 (-0.02%)
TSLA   430.67 (-4.17%)
BABA   273.91 (+0.03%)
CGC   16.03 (+1.84%)
GE   6.24 (-1.73%)
MU   49.54 (+0.79%)
AMD   77.10 (-1.08%)
T   28.59 (-0.14%)
F   6.83 (-0.58%)
ACB   7.34 (+16.14%)
GILD   63.40 (-1.26%)
NFLX   490.19 (+0.58%)
DIS   126.99 (+1.26%)
BAC   23.92 (-2.25%)
BA   156.07 (-0.18%)
S&P 500   3,304.00 (+0.70%)
DOW   27,217.06 (+0.26%)
QQQ   271.42 (+1.46%)
AAPL   111.03 (+0.86%)
MSFT   206.40 (+1.91%)
FB   252.96 (+1.94%)
GOOGL   1,453.78 (+1.65%)
AMZN   3,106.19 (+4.92%)
NVDA   500.59 (-0.02%)
TSLA   430.67 (-4.17%)
BABA   273.91 (+0.03%)
CGC   16.03 (+1.84%)
GE   6.24 (-1.73%)
MU   49.54 (+0.79%)
AMD   77.10 (-1.08%)
T   28.59 (-0.14%)
F   6.83 (-0.58%)
ACB   7.34 (+16.14%)
GILD   63.40 (-1.26%)
NFLX   490.19 (+0.58%)
DIS   126.99 (+1.26%)
BAC   23.92 (-2.25%)
BA   156.07 (-0.18%)
Log in
NYSE:CHE

Chemed Stock Forecast, Price & News

$482.20
+2.68 (+0.56 %)
(As of 09/22/2020 02:06 PM ET)
Add
Compare
Today's Range
$471.74
Now: $482.20
$482.64
50-Day Range
$478.94
MA: $502.51
$523.47
52-Week Range
$330.01
Now: $482.20
$528.29
Volume1,297 shs
Average Volume102,379 shs
Market Capitalization$7.68 billion
P/E Ratio30.31
Dividend Yield0.28%
Beta0.66
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations. Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio.
Read More
Chemed logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 2.3Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.75 out of 5 stars


Industry, Sector and Symbol

Industry Home health care services
Sub-IndustryHealth Care Services
SectorMedical
CUSIP16359R10
Phone513-762-6690

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.94 billion
Cash Flow$17.30 per share
Book Value$45.39 per share

Profitability

Net Income$219.92 million

Miscellaneous

Employees16,641
Market Cap$7.68 billion
Next Earnings Date11/3/2020 (Estimated)
OptionableOptionable
$482.20
+2.68 (+0.56 %)
(As of 09/22/2020 02:06 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CHE News and Ratings via Email

Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Chemed (NYSE:CHE) Frequently Asked Questions

How has Chemed's stock price been impacted by COVID-19 (Coronavirus)?

Chemed's stock was trading at $414.05 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CHE shares have increased by 15.9% and is now trading at $479.79.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Chemed?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Chemed
.

When is Chemed's next earnings date?

Chemed is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Chemed
.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) posted its quarterly earnings data on Wednesday, July, 29th. The company reported $4.41 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.75 by $0.66. The company earned $502.20 million during the quarter, compared to the consensus estimate of $522.90 million. Chemed had a return on equity of 36.71% and a net margin of 12.99%. The firm's revenue was up 6.0% compared to the same quarter last year. During the same quarter last year, the firm posted $3.36 EPS.
View Chemed's earnings history
.

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed announced a quarterly dividend on Thursday, August 6th. Shareholders of record on Monday, August 17th will be given a dividend of $0.34 per share on Friday, September 4th. This represents a $1.36 annualized dividend and a dividend yield of 0.28%. The ex-dividend date of this dividend is Friday, August 14th. This is an increase from Chemed's previous quarterly dividend of $0.32.
View Chemed's dividend history
.

What guidance has Chemed issued on next quarter's earnings?

Chemed issued an update on its FY20 earnings guidance on Wednesday, July, 29th. The company provided earnings per share guidance of $16.20-16.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $16.13.

What price target have analysts set for CHE?

3 brokerages have issued twelve-month price targets for Chemed's stock. Their forecasts range from $490.00 to $535.00. On average, they expect Chemed's share price to reach $520.00 in the next twelve months. This suggests a possible upside of 8.4% from the stock's current price.
View analysts' price targets for Chemed
.

Are investors shorting Chemed?

Chemed saw a decrease in short interest in August. As of August 31st, there was short interest totaling 125,100 shares, a decrease of 31.6% from the August 15th total of 182,900 shares. Based on an average daily trading volume, of 85,800 shares, the days-to-cover ratio is presently 1.5 days. Currently, 0.8% of the shares of the stock are short sold.
View Chemed's Short Interest
.

Who are some of Chemed's key competitors?

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), AbbVie (ABBV), Abbott Laboratories (ABT), Costco Wholesale (COST), Home Depot (HD), Johnson & Johnson (JNJ), Boeing (BA), CVS Health (CVS), Verizon Communications (VZ) and Altria Group (MO).

Who are Chemed's key executives?

Chemed's management team includes the following people:
  • Mr. Kevin J. McNamara, CEO, Pres & Director (Age 65)
  • Mr. David P. Williams, Exec. VP & CFO (Age 58)
  • Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 65)
  • Mr. Spencer S. Lee, Exec. VP (Age 63)
  • Mr. Nicholas Michael Westfall, Exec. VP (Age 40)

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Who are Chemed's major shareholders?

Chemed's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.67%), Neuberger Berman Group LLC (3.98%), Riverbridge Partners LLC (2.12%), FMR LLC (2.11%), Bank of America Corp DE (1.31%) and Bank of New York Mellon Corp (1.26%). Company insiders that own Chemed stock include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs.
View institutional ownership trends for Chemed
.

Which institutional investors are selling Chemed stock?

CHE stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Vanguard Group Inc., Ninety One UK Ltd, FMR LLC, Canada Pension Plan Investment Board, Boston Trust Walden Corp, Riverbridge Partners LLC, and Neuberger Berman Group LLC. Company insiders that have sold Chemed company stock in the last year include Andrea R Lindell, Donald E Saunders, Frank E Wood, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Patrick P Grace, and Spencer S Lee.
View insider buying and selling activity for Chemed
.

Which institutional investors are buying Chemed stock?

CHE stock was acquired by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, WFA of San Diego LLC, WFA of San Diego LLC, Trinity Street Asset Management LLP, Marshall Wace North America L.P., Bank of America Corp DE, Point72 Asset Management L.P., and Teacher Retirement System of Texas.
View insider buying and selling activity for Chemed
.

How do I buy shares of Chemed?

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $479.79.

How big of a company is Chemed?

Chemed has a market capitalization of $7.64 billion and generates $1.94 billion in revenue each year. The company earns $219.92 million in net income (profit) each year or $13.95 on an earnings per share basis. Chemed employs 16,641 workers across the globe.

What is Chemed's official website?

The official website for Chemed is www.chemed.com.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.